Stay updated on APL-2 in wAIHA/CAD Safety, Efficacy Clinical Trial
Sign up to get notified when there's something new on the APL-2 in wAIHA/CAD Safety, Efficacy Clinical Trial page.

Latest updates to the APL-2 in wAIHA/CAD Safety, Efficacy Clinical Trial page
- CheckyesterdayChange DetectedA site-wide notice about NIH’s terminology transition appears above the unchanged 403 error page.SummaryDifference1%

- Check8 days agoChange DetectedThe ClinicalTrials.gov footer revision number changed from v3.7.1 to v3.7.2; the study record remains unavailable behind a 403 error.SummaryDifference0.2%

- Check15 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check35 days agoChange DetectedThe page now shows a 403 Forbidden error page instead of the study record, replacing the previous study content with a generic error screen. This blocks access to the core information and navigation for the study, so users cannot view details, locations, or related materials.SummaryDifference19%

- Check56 days agoChange DetectedThe page revision was updated from v3.6.5 to v3.6.6, signaling a small internal update to the page. There is no change to the visible content or layout based on this revision.SummaryDifference0.1%

- Check77 days agoChange DetectedThe page's revision label was updated from v3.6.4 to v3.6.5, indicating a minor update to the page's revision history.SummaryDifference0.1%

Stay in the know with updates to APL-2 in wAIHA/CAD Safety, Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the APL-2 in wAIHA/CAD Safety, Efficacy Clinical Trial page.